P214 Mepolizumab induction therapy for eosinophilic granulomatosis with polyangiitis (EGPA)

Mepolizumab has been used as an adjuvant therapy for refractory EGPA. We report biopsy confirmed EGPA using conventional doses of Mepolizumab for induction treatment.

http://ift.tt/2iE62tc